Individual results may vary based on several factors, including severity of disease, initiation of treatment, and duration of therapy.
*Based on commercial patients, early access patients, and clinical trial participants through December 2019.
†Includes clinical trial patients.
‡Clinical studies of SPINRAZA did not include sufficient numbers of subjects aged 65 and older to determine whether they respond differently from younger patients.
§Based on commercial patients in the US (including Puerto Rico) through December 2019.